Ontology highlight
ABSTRACT: Background
Bortezomib-induced peripheral neuropathy (BIPN) is a common and debilitating side effect. Our pilot study demonstrated that acupuncture is safe and can decrease total neuropathic symptoms. However, there is lack of knowledge in which individual BIPN symptoms benefited from acupuncture.Purpose
To characterize individual symptoms reduced by acupuncture in patients with BIPN.Methods
Patients with multiple myeloma treated with bortezomib who developed BIPN grade 2 or above, based on National Cancer Institute Common Terminology Criteria for Adverse Events (NCI CTCAE), were enrolled and received 10 acupuncture treatments over 10 weeks. Self-reported BIPN-associated symptoms assessments were collected weekly at baseline, during, and after acupuncture treatment u
SUBMITTER: Zhi WI
PROVIDER: S-EPMC6247555 | biostudies-literature | 2018 Dec
REPOSITORIES: biostudies-literature